GL1X · GenesisL1 explorer

MolNFT v1 · #114893 · protein

Crystal structure of abbb + udp-C-gal (short soak) + di

5C3D · Histo-blood group abo system transferase: “Crystal structure of abbb + udp-C-gal (short soak) + di”. X-ray diffraction, 2 ligands (URM, MN), 4 pockets (best druggability 0.50). MolNFT v1 #114893 on GenesisL1: 3D structure, binding…

PDB
5C3D
Type
protein
Length
278 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Histo-blood group abo system transferase
EC
2.4.1.40, 2.4.1.37
UniProt
P16442
Ligands
URM, MN
Pockets
4 · best druggability 0.50

Structure

x-ray diffraction · 1 distinct chain · 32% helix, 20% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AHisto-blood group abo system transferase (EC 2.4.1.40, 2.4.1.37)protein27832% helix, 20% strandP16442

Ligands and binding sites

  • URM · (((2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)methyl)phosphonic (((2R,3S,4R,5R)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl phosphoric) anhydride · ligand · chains A
  • MN · Manganese (II) ion · metal · chains A
  • PG0 · 2-(2-methoxyethoxy)ethanol · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

4 pockets found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12210.500.7519URM
2740.310.7314empty
3530.310.7617empty
4520.300.7614MN

Compared structures

  • 5C3D · Crystal structure of ABBB + UDP-C-Gal (short soak) + DI · the same entry in another collection · chain A against A, TM-score 1.00
  • P16442 · AlphaFold monomer V2.0 prediction for histo-blood group abo system transferase (P16442) · a predicted model of the same protein · chain A against A, TM-score 0.99

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.